OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2024-12-31-accounts

Draft Financial Statements at 18 July 2025 at

Charity Registration No. 313355

Company Registration No. 00721213 (England and Wales)

THE FELLOWSHIP OF POSTGRADUATE MEDICINE

ANNUAL REPORT AND FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2024

Draft Financial Statements at 18 July 2025 at THE FELLOWSHIP OF POSTGRADUATE MEDICINE

LEGAL AND ADMINISTRATIVE INFORMATION

Council Members Professor Sir Peter Barnes DM DSc FRCP FCCP FMedSci FRS Professor Bernard Cheung MA MB BChir PhD FRCP FCP FHKCP FHKAM Mr Wade Dimitri FRCS Dr Jan Willem Elte MD PhD FRCP FACP FEFIM (Hon) Professor Albert Ferro PhD FRCP FBPhS Dr Timothy Nicholson BSc MSc PhD MRCP MRCPsych Professor Kenneth Redekop PhD Professor Allister Vale MD FRCP FRCPE FRCPG FBTS FBPhS Dr K Baker FRCPE FACP (Appointed 18 March 2024) Dr Neil Dewhurst MD FRCPE FRCP (Appointed 27 February 2024) Dr H Oxenham MD (Appointed 23 July 2024) Secretary Broadway Secretaries Limited Charity number 313355 Company number 00721213 Principal address One Bartholomew Close London EC1A 7BL Auditor HW Fisher Audit Acre House 11-15 William Road London NW1 3ER United Kingdom Investment advisors Rathbone Investment Manager Limited 159 New Bond Street London W1S 2UD

Draft Financial Statements at 18 July 2025 at THE FELLOWSHIP OF POSTGRADUATE MEDICINE

CONTENTS

Page
Council Members' Report 1 - 5
Statement of Council Members' Responsibilities 6
Independent Auditor's report 7 - 9
Statement of financial activities 10
Balance sheet 11
Statement of cash flows 12
Notes to the financial statements 13 - 25

Draft Financial Statements at 18 July 2025 at THE FELLOWSHIP OF POSTGRADUATE MEDICINE

COUNCIL MEMBERS' REPORT (INCLUDING DIRECTORS' REPORT)

FOR THE YEAR ENDED 31 DECEMBER 2024

The members of the Council, who are trustees of the Charity for the purposes of charity law and directors for the purposes of company law, present their report and financial statements for the year ended 31 December 2024.

The financial statements have been prepared in accordance with the accounting policies set out in note 1 to the financial statements and comply with the Articles of Association, Companies Act 2006 and "Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)" (effective 1 January 2019).

The Fellowship of Postgraduate Medicine is a registered charity and a company limited by guarantee, not having a share capital, company registration No. 00721213.

The Council

The Council Members are elected by the Members and constitute directors of the Fellowship for the purposes of the Companies Act 2006 and trustees of the Fellowship for the purposes of charity legislation.

Council members are recruited from the Fellowship's members by written invitation of the President after discussion and approval at Council. A recommendation for a person to be invited to join the Council may be made by the President or any other member of the Fellowship. Council Members are Trustees of the Fellowship, and those in office in 2024 received a briefing on the roles and responsibilities of trustees of a UK charity by the Fellowship's lawyers. Council members are updated as required on Charity Commission best practices.

Objectives and Activities

Organization

The Fellowship of Postgraduate Medicine operates from 11 Chandos Street in London, which it leases from the Medical Society of London. The Fellowship of Postgraduate Medicine was founded to meet the increased demand for training in civilian medicine that followed the end of the Great War (1914-18). The Fellowship came into being late in 1918 as the Inter-allied Fellowship of Medicine, with Sir William Osler as its President. Osler merged the Fellowship with the Postgraduate Medical Association, of which he had been the founding President since 1911. The combined societies were named the Fellowship of Medicine and the Postgraduate Medical Association, with Osler the founding President from October 1919 until his death in December 1919. In 1944, the Fellowship had a further name change to the Fellowship of Postgraduate Medicine.

The Fellowship has always been independent of Government and Universities. It originally had a pioneering role in coordinating and providing an impetus to the development of postgraduate medical education in London and throughout the United Kingdom. With the establishment of other organizations such as the British Postgraduate Medical Federation, the Postgraduate Centre movement in hospitals throughout the country, and the postgraduate activities of Royal College and Faculties, its role changed, and the last regular course organized by the Fellowship took place in 1974. The Fellowship continues to make important contributions to postgraduate medical education through its two journals, scientific and health policy conferences and other meetings, and public outreach.

Draft Financial Statements at 18 July 2025 at THE FELLOWSHIP OF POSTGRADUATE MEDICINE

COUNCIL MEMBERS' REPORT (INCLUDING DIRECTORS' REPORT) (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024

Achievements and Performance

Review of activities in 2024 and plans for 2025 and beyond

The Fellowship of Postgraduate Medicine continued its interest in 2023 in supporting national and international postgraduate medical education through its international journals, the Postgraduate Medical Journal , founded in 1925, and Health Policy and Technology , founded in 2012, and by organizing webinars in association with the Cardiovascular Research Trust, the Healthy Heart Trust. Reports from the Editors-in-Chief of these journals are provided below.

In 2024, the Council recruited additional three new members (Drs Kerri Baker, Neil Dewhurst and Helen Oxenham). In addition, Council signed a Memorandum of Understanding with the Society for Acute Medicine, under which the Fellowship and Society will work together to provide educational content to a wider range of doctors than before. Going forward from 2025 and beyond, it is planned to co-organize educational meetings with the Society for Acute Medicine, the first of which is planned to take place in February 2026 at the Royal College of Physicians. In addition, the Fellowship and Society will also be awarding several prizes annually starting in 2025. The first prize the Net Zero Healthcare Service Prize was awarded in April 2025.

The Fellowship has also entered into an agreement with the London Cardiovascular Society to co-organize three educational events in 2025. This will be a pilot, which will be evaluated after these three meetings have taken place, to assess the value to the Fellowship of continuing this collaboration in the longer term.

Finally, the Fellowship is organizing an educational meeting in December 2025 at the Royal Society of Medicine to celebrate the centenary of the Postgraduate Medical Journal .

Postgraduate Medical Journal : Report by the Editor-in-Chief, Professor Bernard Cheung

The year 2024 marked the second year of publication of the Postgraduate Medical Journal by Oxford University Press. In 2024, the Journal received a total of 2,649 original manuscripts. The vast majority of manuscripts were original research articles, followed by review articles. The number of submissions has increased from 1,845 manuscripts in 2023. In 2022, there were only 1,019 submissions, so the amount of work processing and evaluating manuscripts has been increasing year after year. The substantial increase in manuscript submissions in 2024 is an indication of the high standing of the Postgraduate Medical Journal amongst medical journals and its Impact Factor. The Journal's Impact Factor in 2024 was 3.6, compared to 3.4 in 2023.

Due to the large number of manuscripts, the overall acceptance rate was only 9%. The immediate rejection rate was 82%, similar to 2023. The mean time from submission to final decision was 99 days. The mean time from submission to rejection was 67 days. The Journal continued to receive and publish articles from all over the world. The submitted articles came, in descending order, from China (74%), the UK (3%) and the USA (2%). The acceptance rate for manuscripts from these countries was 5%, 30% and 15%, respectively. The large number of manuscripts from China and the low acceptance rate pose a challenge. We believe the large number of submissions from China may be related to our no-publication-charge policy and our good Impact Factor. The vast majority of immediate rejections were due to the fact that the manuscripts were more suitable for specialist journals or that they made use of large databases to address unimportant research questions.

A major revolution for the Postgraduate Medical Journal was the establishment of an Editorial Board in 2024. The Board members form a pool of global experts with diverse expertise; this change has certainly made it much easier for manuscripts to receive perceptive reviews on time. There has also been a change in the line-up of Associate Editors, with some retirements and some new appointments. Of particular note is the appointment of Dr Tim Cooksley as Section Editor of the Acute Medicine section. He has a wealth of experience in journal editorship and experience in acute medicine.

As the vast majority of readers access the Postgraduate Medical Journal online, there will be a transition to online publication only, which is not only more cost-effective but also environmentally friendly.

The Postgraduate Medical Journal is celebrating its centenary in 2025. The occasion will be celebrated by a medical conference in December 2025, with many distinguished speakers giving lectures incorporating a historical perspective. A special anniversary logo has also been created. We think that the Postgraduate Medical Journal will continue to thrive in its second century; it is superbly positioned to play an important role in updating doctors and other professionals on clinical matters and influencing medical treatment for the better.

Draft Financial Statements at 18 July 2025 at THE FELLOWSHIP OF POSTGRADUATE MEDICINE

COUNCIL MEMBERS' REPORT (INCLUDING DIRECTORS' REPORT) (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024

Health Policy and Technology: Report by the Editor-in-Chief, Professor Ken Redekop

In 2024, there were 626 manuscript submissions, which means that there has been a steady increase in submissions over recent years (458 in 2020, 506 in 2021, 516 in 2022 and 550 in 2023).

The acceptance rate in 2024 was 12%, which is comparable but lower than in previous years (2021: 15%; 2022: 18%; 2023: 16%). Over the years 2021 to 2024, the proportion of desk rejections by the Editor-in-Chief versus standard rejections has been stable at about 75%. It should be noted that such rejection rates are very similar to those of related journals .

In 2024, the average time to the first desk rejection decision decreased compared to 2023 (1.3 versus 2.1 weeks). The average time to the first standard decision was similar to 2023 (24 weeks), while the average time to the standard editorial outcome decreased compared to 2023 (35 weeks versus 38 weeks). However, in both cases, these durations are too long.

The submitted articles came predominantly from authors in China ( n =111), India ( n =68), Turkey ( n =43), Iran ( n =41), and the United States ( n =26). Compared to 2023, there was a decrease in submissions from the United States but an increase in submissions from China and India.

The Journal's impact factor in 2024 was 3.4, which is similar to that in 2023.

An additional achievement in 2024 was the reorganization of the structure of the Editorial Board to ensure that its composition better reflected the topics covered in recent Health Policy and Technology publications. The current membership of the Editorial Board now stands at 23.

Financial review

Results for the year

The income for the year was £974,588 (2023: £994,493) before having taken account of unrealized gain on investments of £329,139 (2023: £201,227) and realized gain on investments of £54,840 (2023: loss of £22,808).

Investment policy and performance

Rathbone Investment Management Limited manages the Fellowship's investment portfolio, subject to the terms of a discretionary management agreement. The investment manager has been instructed by the Fellowship that no purchases are permitted of shares in companies involved in the brewing of alcoholic beverages or the manufacture of tobacco or armaments products. The total investment in any one entity should not exceed 10% of the total portfolio value. Otherwise, there are no restrictions on the charity's power to invest. Details of the Fellowship's investments are set out in note 12 to the accounts.

The investment strategy takes into account income requirements, the risk profile and the investment manager's view of the market prospects in the medium term. The overall investment policy is to maximize total return, both in terms of income and capital appreciation, through a diversified portfolio to minimize risk.

The charity's investment portfolio yielded income of £131,718 (2023: £152,816) and increased in value during the year to a market value to £7,044,980 (2023: increase to £5,536,240). The Council are satisfied with the performance of the investments in the year.

Reserves policy and financial position

The Fellowship maintains a general fund to continue its promotion of postgraduate study of medicine by publishing journals, arranging lectures, symposia and educational and research events from time to time.

The Fellowship's reserves policy is to maintain adequate general reserves to provide continuing income from its invested funds, to have general funds sufficient to meet the requirement for working capital, and to meet any temporary shortfall of funds to enable the Fellowship to achieve its charitable objectives.

The balance sheet shows total funds of £7,545,634 (2023 : £6,654,440). Of this. £76,802 (2023: £14,738) of unrestricted funds have been designated by the Council members for the establishment of the Health, Policy and Technology journal. After deducting this designated fund from the total unrestricted funds, the balance sheet shows general reserves of £7,468,841 (2023: £6,639,702). Council members are reviewing options for the use of reserves in the future. Free reserves are also required to manage future uncertainty in journal income. The trustees consider that this level of free reserves matches the parameters set out in the charity's reserves policy above, and they, therefore, consider the free reserves to be adequate but not excessive.

Draft Financial Statements at 18 July 2025 at THE FELLOWSHIP OF POSTGRADUATE MEDICINE

COUNCIL MEMBERS' REPORT (INCLUDING DIRECTORS' REPORT) (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024

Risk Management

The Treasurer, on behalf of the Council, has undertaken an assessment of the major risks to which the charity is exposed, in particular those relating to the specific operational areas of the charity and its finances, and is working to ensure that controls are in place to mitigate those risks.

The two main risks for the charity, as identified by the trustees, are described below, together with the principal way in which they are mitigated:

This risk is mitigated by Officers and the Council of the Fellowship approving all activities and only doing this after due consideration of a business plan which outlines the financial implications.

This risk is mitigated by the charity keeping files on external computers and by storing records and other administration paperwork offsite at a secure storage location.

Public Benefit

The members of the Council confirm that they have referred to the Charity Commission's guidance on public benefit when reviewing the Fellowship's objectives and aims and in planning future activities for the year.

Going concern assessment

At the time of approving the financial statements, the directors/trustees have a reasonable expectation, based on the level of their reserves, cash held at bank and investments, that the charity has adequate resources to continue in operational existence for the foreseeable future. Thus, the Council continues to adopt the going concern basis of accounting in preparing the financial statements.

Structure, governance and management

Constitution

The charity is a registered charity and a company limited by guarantee, not having a share capital, (incorporated by license of the Department of Trade and Industry), Company Registration No. 00721213.

Organization

The charity operates from 11 Chandos Street in London which it leases from the Medical Society of London.

Draft Financial Statements at 18 July 2025 at THE FELLOWSHIP OF POSTGRADUATE MEDICINE

COUNCIL MEMBERS' REPORT (INCLUDING DIRECTORS' REPORT) (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024

The Council

The Council Members are elected by the Members and constitute directors of the Fellowship for the purposes of the Companies Act 2006 and trustees of the Fellowship for the purposes of charity legislation.

The Council Members, who are also the directors for the purpose of company law, and who served during the year and up to the date of signature of the financial statements were:

Professor Sir Peter Barnes DM DSc FRCP FCCP FMedSci FRS Professor Bernard Cheung MA MB BChir PhD FRCP FCP FHKCP FHKAM Dr Kerri Baker FRCPE FACP Appointed on 18 March 2024 Dr Jan Willem Elte MD PhD FRCP FACP FEFIM (Hon) Mr Wade Dimitri FRCS Professor Albert Ferro PhD FRCP FBPhS Dr Timothy Nicholson BSc MSc PhD MRCP MRCPsych Honorary Secretary Professor Kenneth Redekop PhD Professor Allister Vale MD FRCP FRCPE FRCPG FBTS FBPhS President Dr Neil Dewhurst MD FRCPE FRCP Appointed on 27 February 2024 Dr Helen Oxenham MD Appointed on 23 July 2024

Appointed on 18 March 2024 Honorary Treasurer from 1 January 2024 Honorary Secretary

None of the Council Members has any beneficial interest in the company. All of the Council Members are members of the company and guarantee to contribute £1 in the event of a winding up.

Management of the Fellowship's affairs is directed by its officers, the President, Honorary Secretary and Honorary Treasurer. Financial matters are monitored and handled by the President and Honorary Treasurer, with operational matters dealt with under the Treasurer's direction and responsibility. Investment decisions are delegated to the Fellowship's Investment Manager at Rathbones Investment Management Limited and monitored by the President and Honorary Treasurer.

Key management personnel

The Council Members consider that they comprise the key management of the Charity and are in charge of directing, controlling, running, and operating the Charity on a day-to-day basis.

No Council Member received any remuneration for services as a member of the Council during the year (2023 : none).

Disclosure of information to the auditor

Each of the Council Members has confirmed that there is no information of which they are aware that is relevant to the audit, but of which the auditor is unaware. They have further confirmed that they have taken appropriate steps to identify such relevant information and to establish that the auditor is aware of such information.

The Council Members' report was approved by the Board of Council Members.

..............................

Professor Albert Ferro PhD FRCP FBPhS

Dated: .........................

Draft Financial Statements at 18 July 2025 at THE FELLOWSHIP OF POSTGRADUATE MEDICINE

STATEMENT OF COUNCIL MEMBERS' RESPONSIBILITIES

FOR THE YEAR ENDED 31 DECEMBER 2024

The Council Members, who are also the directors of The Fellowship of Postgraduate Medicine for the purpose of company law, are responsible for preparing the Council Members' Report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).

Company Law requires the Council Members to prepare financial statements for each financial year which give a true and fair view of the state of affairs of the charity and of the incoming resources and application of resources, including the income and expenditure, of the charitable company for that year.

In preparing these financial statements, the Council Members are required to:

The Council Members are responsible for keeping adequate accounting records that disclose with reasonable accuracy at any time the financial position of the charity and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the charity and, hence, for taking reasonable steps to prevent and detect fraud and other irregularities.

Draft Financial Statements at 18 July 2025 at THE FELLOWSHIP OF POSTGRADUATE MEDICINE

INDEPENDENT AUDITOR'S REPORT

TO THE MEMBERS OF THE FELLOWSHIP OF POSTGRADUATE MEDICINE

Opinion

We have audited the financial statements of The Fellowship of Postgraduate Medicine (the ‘charity’) for the year ended 31 December 2024 which comprise the statement of financial activities, the balance sheet, the statement of cash flows and the notes to the financial statements, including significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).

In our opinion, the financial statements:

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the charity in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the Council Members' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the charity’s ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorized for issue.

Our responsibilities and the responsibilities of the Council Members with respect to going concern are described in the relevant sections of this report.

Other information

The other information comprises the information included in the annual report other than the financial statements and our auditor's report thereon. The Council Members are responsible for the other information contained within the annual report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of our audit:

Matters on which we are required to report by exception

In the light of the knowledge and understanding of the charity and its environment obtained in the course of the audit, we have not identified material misstatements in the directors' report included within the Council Members' report.

Draft Financial Statements at 18 July 2025 at THE FELLOWSHIP OF POSTGRADUATE MEDICINE

INDEPENDENT AUDITOR'S REPORT (CONTINUED)

TO THE MEMBERS OF THE FELLOWSHIP OF POSTGRADUATE MEDICINE

We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:

Responsibilities of Council Members

As explained more fully in the statement of Council Members' responsibilities, the Council Members, who are also the directors of the charity for the purpose of company law, are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the Council Members determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. In preparing the financial statements, the Council Members are responsible for assessing the charity’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the Council Members either intend to liquidate the charitable company or to cease operations, or have no realistic alternative but to do so.

Auditor's responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud, is detailed below.

As part of our planning process:

The key procedures we undertook to detect irregularities including fraud during the course of the audit included:

Draft Financial Statements at 18 July 2025 at THE FELLOWSHIP OF POSTGRADUATE MEDICINE

INDEPENDENT AUDITOR'S REPORT (CONTINUED)

TO THE MEMBERS OF THE FELLOWSHIP OF POSTGRADUATE MEDICINE

Owing to the inherent limitations of an audit, there is an unavoidable risk that we may not have detected some material misstatements in the financial statements even though we have properly planned and performed our audit in accordance with auditing standards. The primary responsibility for the prevention and detection of irregularities and fraud rests with the trustees of the charity.

A further description of our responsibilities is available on the Financial Reporting Council’s website at: https://www.frc.org.uk/ auditors responsibilities. This description forms part of our auditor's report.

Use of our report

This report is made solely to the charitable company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the charitable company's members those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the charitable company and the charitable company’s members as a body, for our audit work, for this report, or for the opinions we have formed.

(Senior Statutory Auditor)

for and on behalf of HW Fisher Audit

Chartered Accountants Statutory Auditor Acre House 11-15 William Road London NW1 3ER United Kingdom

.........................

Draft Financial Statements at 18 July 2025 at THE FELLOWSHIP OF POSTGRADUATE MEDICINE

STATEMENT OF FINANCIAL ACTIVITIES INCLUDING INCOME AND EXPENDITURE ACCOUNT

FOR THE YEAR ENDED 31 DECEMBER 2024

Unrestricted Unrestricted
funds funds
2024 2023
Notes £ £
Income and endowments from:
Charitable activities 3 788,588 826,152
Investments 4 177,010 168,341
Other income 5 8,990 -
Total income 974,588 994,493
Expenditure on:
Investment management 6 39,459 32,558
Charitable activities 7 401,530 453,037
Total resources expended 440,989 485,595
Net gains/(losses) on investments 11 383,979 178,419
Net movement in funds 917,578 687,317
Fund balances at 1 January 2024 6,654,440 5,967,123
Fund balances at 31 December 2024 7,572,018 6,654,440

The statement of financial activities includes all gains and losses recognised in the year.

All income and expenditure derive from continuing activities.

The statement of financial activities also complies with the requirements for an income and expenditure account under the Companies Act 2006.

Draft Financial Statements at 18 July 2025 at THE FELLOWSHIP OF POSTGRADUATE MEDICINE

BALANCE SHEET

AS AT 31 DECEMBER 2024

Notes
Fixed assets
Tangible assets
12
Investments
13
Current assets
Debtors
15
Cash at bank and in hand
Creditors: amounts falling due within one year
16
Net current assets
Total assets less current liabilities
Creditors: amounts falling due after more than
one year
18
Net assets
Income funds
Unrestricted funds
Designated funds
21
General unrestricted funds
The financial statements were approved by the Council Members on		 2024
£
294,082
373,109
667,191
(82,029)
-
7,572,018
.........................		 £
1,876
7,044,980
7,046,856
585,162
7,632,018
(60,000)
7,572,018
7,572,018
7,572,018		 2023
£
247,621
1,081,241
1,328,862
(125,060)
14,738
6,639,702		 £
4,398
5,536,240
5,540,638
1,203,802
6,744,440
(90,000)
6,654,440
6,654,440
6,654,440

.............................. Professor Albert Ferro PhD FRCP FBPhS Trustee

Company Registration No. 00721213

Draft Financial Statements at 18 July 2025 at THE FELLOWSHIP OF POSTGRADUATE MEDICINE

STATEMENT OF CASH FLOWS

FOR THE YEAR ENDED 31 DECEMBER 2024

2024
Notes
£
Cash flows from operating activities
Cash generated from operations
23
Investing activities
Cash introduced into investment portfolio
(1,000,000)
Investment income received
12,790
Net cash used in investing activities
Net cash used in financing activities
Net decrease in cash and cash equivalents
Cash and cash equivalents at beginning of year
Cash and cash equivalents at end of year		 £
279,078
(987,210)
-
(708,132)
1,081,241
373,109		 2023
£
(500,000)
16,155		 £
166,223
(483,845)
-
(317,622)
1,398,863
1,081,241

Draft Financial Statements at 18 July 2025 at THE FELLOWSHIP OF POSTGRADUATE MEDICINE

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2024

1 Accounting policies

Charity information

The Fellowship of Postgraduate Medicine is a private company limited by guarantee incorporated in England and Wales. The registered office is One Bartholomew Close, London, United Kingdom, EC1A 7BL.

1.1 Accounting convention

The financial statements have been prepared in accordance with the charity's Articles of Association, the Companies Act 2006 and “Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019). The charity is a Public Benefit Entity as defined by FRS 102.

The financial statements are prepared in sterling, and rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, modified to include the revaluation of investments at fair value. The principal accounting policies adopted are set out below.

1.2 Going concern

At the time of approving the financial statements, the trustees have a reasonable expectation, based on the level of their reserves, cash held at bank and investments, that the charity has adequate resources to continue in operational existence for the foreseeable future. Thus, the Council continue to adopt the going concern basis of accounting in preparing the financial statements.

1.3 Charitable funds

The general fund comprises those monies which may be used towards meeting the charitable objectives of the Fellowship at the discretion of the Council.

The designated fund comprises monies set aside by the Council for specific purposes.

1.4 Income

Income is recognized in the period in which the charity has entitlement to the income, the amount of income can be measured reliably and it is probable that the income will be received.

Income comprises investment income, income from publications and conferences.

Income from publications and conferences is recognized on a receivable basis in the financial year to which it relates.

Dividends are recognized once the dividend has been declared and notification has been received of the dividend due.

Interest on funds held on deposit is included when receivable and the amount can be measured reliably by the charity; this is normally upon notification of the interest paid or payable by the bank.

Draft Financial Statements at 18 July 2025 at THE FELLOWSHIP OF POSTGRADUATE MEDICINE

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024

1 Accounting policies

(Continued)

1.5 Expenditure

Liabilities are recognized as expenditure as soon as there is a legal or constructive obligation committing the charity to make a payment to a third party, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably.

All expenditure is accounted for on an accruals basis. Expenditure comprises direct costs and support costs. All expenses, including support costs, are allocated or apportioned to the applicable expenditure headings. The classification between activities is as follows:

All expenditure is stated inclusive of irrecoverable VAT.

Allocation of support and governance costs

Support costs represent indirect charitable expenditure. In order to carry out the primary purposes of the charity it is necessary to provide support in the form of personnel development, financial procedures, provision of office services and equipment and a suitable working environment.

Governance costs comprise the costs involving the public accountability of the charity (including audit costs) and costs in respect to its compliance with regulation and good practice.

Support costs and governance costs are apportioned based on an estimation of the usage of the office at 11 Chandos Street.

1.6 Tangible fixed assets

All assets costing more than £1,000 and with a useful economic life exceeding one year are capitalised.

Tangible fixed assets are initially measured at cost and subsequently measured at cost net of depreciation and any impairment losses.

Depreciation is recognised so as to write down the cost of tangible fixed assets over their expected useful lives as follows:

Computers 25% on cost

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is recognized in net income/(expenditure) for the year.

1.7 Fixed asset investments

Listed investments are a form of basic financial instrument and are initially recognized at their transaction value and subsequently measured at their fair value as at the balance sheet date using the closing quoted market price.

Realized gains (or losses) on investment assets are calculated as the difference between disposal proceeds and their opening carrying value or their purchase value if acquired subsequent to the first day of the financial year. Unrealized gains and losses are calculated as the difference between the fair value at the year end and their carrying value at that date. Realized and unrealized investment gains (or losses) are combined in the statement of financial activities and are credited (or debited) in the year in which they arise.

Draft Financial Statements at 18 July 2025 at THE FELLOWSHIP OF POSTGRADUATE MEDICINE

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024

1 Accounting policies

(Continued)

1.8 Cash and cash equivalents

Cash at bank and in hand represents such accounts and instruments that are available on demand or have a maturity of less than three months from the date of acquisition.

1.9 Financial instruments

The charity has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Other than fixed asset investments, the charity only has financial assets and financial liabilities of a kind initially recognized at transaction value and subsequently measured at their settlement value.

The charity does not acquire put options, derivatives or other complex financial instruments.

1.10 Leased asset

Rentals applicable to operating leases where substantially all of the benefits and risks of ownership remain with the lessor are charged to the statement of financial activities on a straight line basis over the lease term.

2 Critical accounting estimates and judgements

In the application of the charity’s accounting policies, the Council Members are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognized in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods. There were no critical accounting estimates or judgements in the year in question.

Draft Financial Statements at 18 July 2025 at THE FELLOWSHIP OF POSTGRADUATE MEDICINE

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

FOR THE YEAR ENDED 31 DECEMBER 2024

3 Charitable activities

Postgraduate Health Policy Other Journal Total Postgraduate Health Policy Other Journal Total
Medical Journal and Technology Income 2024 Medical Journal and Technology Income 2023
Journal Journal
2024 2024 2024 2023 2023 2023
£ £ £ £ £ £ £ £
Publishing income 738,210 47,700 2,678 788,588 743,994 39,281 42,877 826,152

Draft Financial Statements at 18 July 2025 at THE FELLOWSHIP OF POSTGRADUATE MEDICINE

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024

4
5
6		 Investments
Unrestricted
Unrestricted
funds
funds
2024
2023
£
£
Income from listed investments
131,718
152,186
Interest receivable
45,292
16,155
177,010
168,341
Other income
Unrestricted
Total
funds
2024
2023
£
£
Other Income
8,990
-
Investment management
Unrestricted
Unrestricted
funds
funds
2024
2023
£
£
Fundraising and publicity
Investment management fees
36,864
32,089
Foreign exchange losses, (gains) on cash held in portfolio
2,595
469
39,459
32,558		 Investments
Unrestricted
Unrestricted
funds
funds
2024
2023
£
£
Income from listed investments
131,718
152,186
Interest receivable
45,292
16,155
177,010
168,341
Other income
Unrestricted
Total
funds
2024
2023
£
£
Other Income
8,990
-
Investment management
Unrestricted
Unrestricted
funds
funds
2024
2023
£
£
Fundraising and publicity
Investment management fees
36,864
32,089
Foreign exchange losses, (gains) on cash held in portfolio
2,595
469
39,459
32,558
32,558

Draft Financial Statements at 18 July 2025 at

THE FELLOWSHIP OF POSTGRADUATE MEDICINE

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

FOR THE YEAR ENDED 31 DECEMBER 2024

7 Charitable activities

Postgraduate
Medical
Journal
Seminars and
events
Health policy
and
Technology
2024
2024
2024
£
£
£
Acute Medicine Sponsorship
-
10,000
-
Production
19,161
-
-
Honorarium
24,000
-
12,000
Publisher's Editorial costs
14,537
-
-
Publishers' fees
-
-
2,000
Editorial Board costs
62,936
-
-
Costs of Editorial Office
-
-
14,270
Publisher's share of surplus
177,278
-
-
Other direct costs
2,042
-
-
Marketing
2,760
-
-
Copy editing
170
-
-
Typesetting
5,394
-
-
Printing & binding
1,560
-
-
309,838
10,000
28,270
Share of support costs (see note 8)
18,614
601
1,698
Share of governance costs (see note 8)
18,286
2,650
11,573
346,738
13,251
41,541		 Total
2024
Postgraduate
Medical
Journal
Seminars and
events
Health policy
and
Technology
2023
2023
2023
£
£
£
£
10,000
-
-
-
19,161
60,782
-
-
36,000
-
-
-
14,537
13,950
-
14,637
2,000
-
-
4,000
62,936
64,812
-
12,000
14,270
-
11,385
-
177,278
171,502
-
-
2,042
2,860
-
-
2,760
4,701
-
-
170
3,274
-
-
5,394
5,340
-
-
1,560
1,560
-
-
348,108
328,781
11,385
30,637
20,913
39,554
1,390
3,741
32,509
33,238
1,168
3,143
401,530
401,573
13,943
37,521		 Total
2023
£
-
60,782
-
28,587
4,000
76,812
11,385
171,502
2,860
4,701
3,274
5,340
1,560
370,803
44,685
37,549
453,037

Draft Financial Statements at 18 July 2025 at

THE FELLOWSHIP OF POSTGRADUATE MEDICINE

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

FOR THE YEAR ENDED 31 DECEMBER 2024

7 Charitable activities

(Continued)

During the year, the nominal 'Fellowship members' subscriptions' was renamed to 'Publishers' fees' to reflect a more accurate description of the costs made.

The Postgraduate Medical Journal incurred £228,902 as direct publishers costs and £86,636 which were attributed to the Charity (£24,000 Honoraium and £62,936 of Editorial Board costs.) The journal generated a surplus of £392,372 for the charity.

Draft Financial Statements at 18 July 2025 at THE FELLOWSHIP OF POSTGRADUATE MEDICINE

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024

8 Support costs

Support costs
Governance
costs
£
£
Depreciation
2,522
-
Rent, rates, light and heat
16,425
-
Office equipment < £1,000
191
-
Legal and professional fees
2,014
-
Other costs
(239)
-
Audit fees
-
14,100
Accountancy
-
18,409
20,913
32,509
Analyzed between
Charitable activities
20,913
32,509		 2024
Support costs
Governance
costs
£
£
£
2,522
2,764
-
16,425
16,817
-
191
10,436
-
2,014
15,204
-
(239)
(536)
-
14,100
-
15,750
18,409
-
21,799
53,422
44,685
37,549
53,422
44,685
37,549		 2023
£
2,764
16,817
10,436
15,204
(536)
15,750
21,799
82,234
82,234

Governance costs includes payments to the auditors of £13,100 (2023- £15,750) for audit fees and £6,016 (2023- £5,680) for accountancy services.

9 Council Members

No Council Members (or any persons connected with them) received any remuneration for services as Council members . Professor Ken Redekop, a member of the Council, received an honorarium as Editor-in-Chief of Health, Policy and Technology £12,000 in 2024 (2023: £12,000). Professor Bernard Cheung received £24,000 (2023 : £27,468) as Editor-In-Chief of the Postgraduate Medical Journal. In addition, Professor Albert Ferro and Mr Wade Dimitri received £6,204 and £2,007, respectively, as Associate Editors of Postgraduate Medical Journal .

Total expenses of £11,843 (2023 - £4,536) were reimbursed to members of the Council in connection with core Fellowship business, including attendance at the Annual General meeting in London, and work on the journals. These amounts related predominantly to the reimbursement of event and equipment cost. Individuals are not remunerated in their capacity as members of the Council.

10 Employees

There were no employees in the current or prior year.

11 Net gains/(losses) on investments

Unrestricted Unrestricted
funds funds
2024 2023
£ £
Revaluation of investments 329,139 201,227
Gain/(loss) on sale of investments 54,840 (22,808)
383,979 178,419

Draft Financial Statements at 18 July 2025 at THE FELLOWSHIP OF POSTGRADUATE MEDICINE

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024

12 Tangible fixed assets

Cost
At 1 January 2024
At 31 December 2024
Depreciation and impairment
At 1 January 2024
Depreciation charged in the year
At 31 December 2024
Carrying amount
At 31 December 2024
At 31 December 2023		 Computers
£
15,468
15,468
11,070
2,522
13,592
1,876
4,398

13 Fixed asset investments

Listed
investments
Cash in portfolio
£
Cost or valuation
At 1 January 2024
5,265,067
271,173
Additions
3,896,664
(3,896,664)
Valuation changes
329,139
-
Exchange losses on cash in portfolio
-
(2,595)
Dividend income
-
164,220
Investment manager fees
-
(36,864)
Cash imbursement
-
1,000,000
Disposals
(2,929,283)
2,984,123
At 31 December 2024
6,561,587
483,393
Carrying amount
At 31 December 2024
6,561,587
483,393
At 31 December 2023
5,265,067
271,173
14
Financial instruments
2024
£
Carrying amount of financial assets
Instruments measured at fair value through profit or loss
6,546,998		 Total
£
5,536,240
-
329,139
(2,595)
164,220
(36,864)
1,000,000
54,840
7,044,980
7,044,980
5,536,240
2023
£
5,265,067

Draft Financial Statements at 18 July 2025 at THE FELLOWSHIP OF POSTGRADUATE MEDICINE

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024

15 Debtors

Debtors
Amounts falling due within one year:
Trade debtors
Other debtors
Prepayments and accrued income		 2024
£
193,231
38,429
62,422
294,082		 2023
£
200,502
11,838
35,281
247,621

16 Creditors: amounts falling due within one year

Notes
Other taxation and social security
Deferred income
20
Trade creditors
Accruals		 2024
£
-
30,000
4,842
47,187
82,029		 2023
£
13,398
30,000
47,475
34,187
125,060

17 Liability of members

The Fellowship is constituted as a company limited by guarantee. In the event of the Fellowship being wound up members are required to contribute an amount not exceeding £1.

18 Creditors: amounts falling due after more than one year

Creditors: amounts falling due after more than one year
2024 2023
Notes £ £
Deferred income 20 60,000 90,000

19 Taxation

The Fellowship of Postgraduate Medicine is a registered charity and therefore is not liable to income tax or corporation tax on income derived from its charitable activities, as it falls within the various exemptions available to registered charities.

Draft Financial Statements at 18 July 2025 at THE FELLOWSHIP OF POSTGRADUATE MEDICINE

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024

20
Deferred income
Other deferred income
Deferred income is included in the financial statements as follows:
Current liabilities
Non-current liabilities		 2024
£
90,000
2024
£
30,000
60,000
90,000		 2023
£
120,000
2023
£
30,000
90,000
120,000

Draft Financial Statements at 18 July 2025 at THE FELLOWSHIP OF POSTGRADUATE MEDICINE

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

FOR THE YEAR ENDED 31 DECEMBER 2024

21 Designated funds

The income funds of the charity include the following designated funds which have been set aside out of unrestricted funds by the trustees for specific purposes:

Movement in funds Movement in funds Movement in funds Movement in funds
Balance at Incoming Resources Balance at Incoming Resources Transfers Balance at
1 January 2023 resources expended 1 January 2024 resources expended 31 December
2024
£ £ £ £ £ £ £ £
Health, Policy and Technology Journal 12,978 39,281 (37,521) 14,738 42,700 (28,270) (29,168) -
12,978 39,281 (37,521) 14,738 42,700 (28,270) (29,168) -

The Health, Policy and Technology Journal was established and began publication in 2012. £300,000 was originally set aside by the Council members in connection with the establishment of the new Journal and the working capital required. The trustees transferred the surplus funds into the main fund in year ending 31st December 24.

Draft Financial Statements at 18 July 2025 at THE FELLOWSHIP OF POSTGRADUATE MEDICINE

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024

22 Operating lease commitments

At the reporting end date the charity had outstanding commitments for future minimum lease payments under noncancellable operating leases, which fall due as follows:

2024 2023
£ £
Within one year 10,200 10,200

23 Related party transactions

During the prior year the Charity made a donation of £nil to Hippocrates Prize for Poetry and Medicine . None was awarded this year.

The Hippocrates Prize is organized by the Hippocrates Initiative an unincorporated society, founded and jointly managed by Professor D R J Singer, former Trustee and President of the Fellowship of Postgraduate Medicine.

24 Cash generated from operations
24 Cash generated from operations 2024 2023
£ £
Surplus for the year 917,578 687,317
Adjustments for:
Investment income recognized in statement of financial activities (177,010) (168,341)
Foreign exchange differences 2,595 469
(Gain)/loss on disposal of investments (54,840) 22,808
Fair value gains and losses on investments (329,139) (201,227)
Depreciation and impairment of tangible fixed assets 2,522 2,764
Investment managers fees charged in portfolio 36,864 32,089
Movements in working capital:
(Increase) in debtors (46,461) (81,683)
(Decrease) in creditors (43,031) (97,973)
(Decrease) in deferred income (30,000) (30,000)
Cash generated from operations 279,078 166,223
25 Analysis of changes in net funds
The charity had no debt during the year.